



Arrhythmias in the Adult with Congenital 
Heart Disease 
(CCTGA), the (longstanding) hemodynamic issues caused by the heart 
defect, and/or the result of prior surgery. In general, atrial arrhythmias 
are seen in patients who have atrial defects (such as atrial septal defect 
(ASD)) or who have undergone extensive atrial surgery (e.g. Mustard’s 
operation for transposition of the great arteries (TGA) or the Fontan 
operation for single ventricle) and ventricular arrhythmias occur in 
patients who have undergone ventricular surgery (e.g. tetralogy of 
Fallot (TOF) or double outlet right ventricle). However, there are many 
exceptions. Atrial arrhythmias, for instance, may be the result of 
longstanding atrial hypertrophy secondary to a noncompliant ventricle 
and are often seen in adults with repaired TOF. 
It is also important to keep in mind the close interaction between 
arrhythmia and hemodynamic problems. Indeed it may be hard to say 
which is the cause and which the effect in a given patient. Longstanding 
hemodynamic problems can lead to arrhythmias which, in turn, lead to 
further hemodynamic deterioration. Similarly, chronic bradycardia or 
junctional rhythm with atrio-ventricular (AV) dissociation can be the 
cause of cardiac failure. 
PREVALENCE                                                                       
The remarkable success of cardiac surgery for CHD has now created a 
large pool of adults with CHD in developed countries. Indeed, it is now 
estimated that in countries such as the USA, for the fi rst time in history, 
there are more adults than children with CHD.(1) In these patients, 
there are specifi c arrhythmias that are seen (such as incisional atrial 
reentrant tachycardia (IART)), which impose a severe burden of care. In 
the developing world, it is mostly patients with the simpler heart defects 
(such as ASD, ventricular septal defect (VSD), TOF, etc.) who survive to 
adulthood, but the natural history of these defects also makes them 
prone to arrhythmias (atrial fi brillation (AF) for instance in the 
unrepaired ASD patient). 
BRADYARRHYTHMIAS                                                       
In general, bradyarrhythmias are rare in the unoperated patient and the 
commonest cause of signifi cant bradycardia is surgical trauma to either 
the sinus or AV node. 
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Arrhythmias are an important problem 
in adults with congenital heart disease, whether previously 
operated upon or not. This article discusses the incidence, 
pathogenesis, diagnosis and management of arrhythmias in 
the adult congenital patient. Arrhythmias can be the cause 
or the effect of hemodynamic deterioration. Complex 
patients, such as those with transposition of the great 
arteries, tetralogy of Fallot and single ventricle problems 
are highly likely to have major arrhythmias during adult 
life. Early recognition and appropriate management can 
improve the patient’s life and can even prevent early death. 
Pacemaker placement should be considered for bradycardia. 
Tachyarrhythmia patients may need a combination of drug 
therapy, catheter ablation, pacemaker for antitachycardia 
pacing, or reoperation for residual structural issues 
combined with arrhythmia surgery. Sudden death is 
another major problem and risk stratifi cation strategies 
will be discussed. Appropriate and early use of implantable 





INTRODUCTION                                                                 
Arrhythmias are an important problem in adults with congenital heart 
disease (CHD) and cause morbidity and mortality whether the CHD 
was previously repaired or not. Arrhythmias may be the result of natural 
history of the underlying congenital cardiac abnormality (e.g. heart 
block in congenitally corrected transposition of the great arteries 
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In the rare patient with heterotaxy syndrome due to left atrial isomerism 
(usually associated with polysplenia) there may be a developmental 
absence or maldevelopment of the sinus node with bradycardia.(2) 
In patients with CCTGA (or single ventricle with CCTGA-like ventricular 
relationship) there is a natural tendency towards AV block with 
bradycardia. This is due to the fact that these patients have an AV node 
that is anteriorly displaced. These patients also are more vulnerable to 
developing heart block during surgery for VSD (a common associated 
condition).(3) 
Sinus node dysfunction is a common problem late after surgery in the 
region of the node or its arterial supply. The commonest patients with 
this problem are those who have had an atrial repair (Mustard’s or 
Senning’s operation) for TGA, and Fontan operation for functional 
single ventricles. Both of these operations involve much atrial dissection 
and suture lines. Sinus node damage used to be a problem in patients 
undergoing ASD repair, but this has largely been resolved with better 
knowledge of the anatomy of the sinus node and its arterial supply.(4) 
AV node damage is usually secondary to operations such as VSD, TOF, 
AV canal and CCTGA with VSD repair. While most of these occur 
immediately after surgery in childhood, there is a small incidence of late 
appearing AV block.(5) Management of bradyarrhythmias is by pacemaker 
implantation.
PACEMAKER IMPLANTATION                                         
Endocardial pacemaker (or implantable cardioverter defi brillator (ICD)) 
implantation can be far from routine in CHD patients. It is important to 
perform angiography of the veins that the operator hopes to use to 
make sure there are no congenital venous abnormalities (such as left 
superior vena cava draining to the coronary sinus) or acquired venous 
abnormalities such as stenoses or occlusion from prior cannulation for 
surgery, peri-operative care or cardiac catheterization. For instance, 
patients who have had Mustard’s operation for TGA may have stenoses 
in their baffl es that redirect systemic venous blood.(6) 
A thorough knowledge of the patient’s anatomy and prior surgery is 
important. For instance, during the Fontan operation, the right atrium 
(or the great veins) is directly connected to the pulmonary arteries and 
thus venous access to the ventricles is lost. Residual intracardiac right to 
left shunts may pose a problem since pacemaker patients may develop 
thrombi around the leads with potential for systemic embolization. 
Knowledge of such aspects may cause the team to opt for an epicardial 
approach in some patients. 
TACHYARRHYTHMIAS                                                      
Wolff Parkinson White syndrome, Accessory Pathways and AV 
nodal reentrant tachycardia
Patients with Ebstein’s anomaly of the tricuspid valve have a signifi cant 
incidence of accessory pathways with a higher likelihood of multiple 
accessory pathways as well.(7) They are prone to AV reentrant 
tachycardia. As seen in patients with Wolff Parkinson White syndrome 
(WPW) without CHD, they also have a small risk of sudden death. 
While catheter ablation is usually curative, the ablation procedures are 
more diffi cult due to the complex anatomy of the tricuspid valve 
annulus, with lower acute success and a higher chance of pathway 
recurrence.(8) 
Although not technically an accessory pathway, some rare patients with 
ambiguous atrial arrangement (heterotaxy syndrome) can have two AV 
nodes, one anterior and the other posterior, with a sling of conduction 
tissue (the Monckeburg sling) connecting the two, with the possibility of 
a rare form of AV nodal reentrant tachycardia where the circuit goes 
from one AV node to the other and then turns around in the 
atrium.(9) 
Even otherwise, patients with CHD may develop dual AV nodal 
pathways and go on to have AVNRT. 
The main treatment options are medical therapy with drugs or catheter 
ablation. 
INCISIONAL ATRIAL REENTRANT TACHYCARDIA 
(IART) AND ATRIAL FLUTTER (AFL)
Atrial fl utter (AFL) is an important problem in adults with unrepaired 
ASDs. Repair in childhood appears to prevent the development of AFL. 
Later repair in adulthood seems to prevent arrhythmias but does not 
help if the arrhythmias have already started to occur.(10, 11) 
IART goes by many names such as atypical AFL, scar-based AFL or 
sometimes just plain AFL. However, it is quite different from AFL in 
patients without CHD. This is not to say that AFL of the usual variety 
does not happen in CHD patients. Atrial stretch due to longstanding 
unrepaired CHD can lead to AFL that rotates around the cavo-tricuspid 
isthmus (as it does in normal hearts and those with unrepaired ASD). 





Also, many patients with IART have rhythms that utilize the cavo-
tricuspid isthmus.(12) However, even in these two categories of patients, 
the rhythm tends to be slower and may not show the typical saw-
toothed p-waves associated with usual atrial fl utter because of the 
underlying CHD (Figure 1). 
IART is a macro-rentrant atrial tachycardia where the rhythm rotates 
around one or more scars in the atrium. It predominantly tends to be 
in the right (systemic venous) atrium, and the atrial rate is slower than 
typical AFL. While any atrial scar can lead to IART, the incidence seems 
to increase with complexity of surgery and other residual problems 
that lead to atrial hypertrophy or stretch. Thus, it can occur after a 
“simple” ASD operation, but tends to be more common after atrial 
repair (Mustard’s or Senning’s type) for TGA. The most commonly 
affected patient is one who has had a Fontan operation (or one of its 
numerous modifi cations).(12) 
IART tends to be slower in rate, which is a disadvantage since it 
predisposes to 1:1 conduction to the ventricle, making the patient 
more symptomatic. Furthermore, the atrial scars can bestow unusual 
shapes to the p-wave (or even rarely the absence of p waves or low-
amplitude, fragmented p waves). P-waves can be hard to see and the 
rhythm may be mistaken for something else, such as sinus tachycardia. 
The clue, however, is in the patient’s symptoms, and the fact that most 
of these patients have underlying sinus node dysfunction. It is not 
unusual to see so-called “tachycardias” with rates as low as 100-150. 
The diagnosis can be made manifest with administration of adenosine, 
which usually unmasks p waves hiding under the QRS complexes. Also, 
it is not unusual for a single patient to have multiple IART circuits. 
Acute treatment of IART to convert the rhythm to sinus consists of: 
electrical cardioversion, chemical cardioversion with drugs such as 
ibutilide, amiodarone, etc. and overdrive pacing, either via a trans-
esophageal or intracardiac atrial electrode, or via a pre-existing 
pacemaker. 
Chronic treatment is directed mainly towards rhythm control (rather 
than rate control, which is sometimes used as a last resort) and 
anticoagulation to prevent thromboembolic complications. Rhythm 
control may be achieved using one of four options: drug therapy, 
catheter ablation, atrial anti-tachycardia pacing and surgical ablation. 
Drug therapy often involves the use of class 3 (sotalol, amiodarone, 
dofetilide) or 1C (fl ecainide, propafenone) antiarrhythmics. These 
potent drugs come with the risk of lethal proarrhythmia and need to 
be initiated in hospital. Furthermore, they can exacerbate the preexistent 
 FIGURE 1: Slow incisional atrial reentrant tachycardia (IART) with 1:1 atrioventricular conduction in an adult Fontan patient. The rhythm can easily be mistaken for sinus. 
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tendency to bradyarrhythmia and push the patient towards need for a 
pacemaker. Chronic use of amiodarone can also lead to multisystem 
problems such as hepatic failure, thyroid abnormalities, pulmonary 
disease and optic neuropathy. 
Catheter ablation is now becoming the rage for IART since it offers the 
hope of a cure without too much risk. However, the anatomical and 
electrophysiological complexity of these patients leads to a lower 
immediate success rate, and worse, a signifi cant incidence of recurrence. 
The procedures can be long and complex and need specialized 
laboratories and specialized personnel to be successful. Detailed 
mapping of the tachycardia circuits is important.(12) The advent of 
3-dimensional electroanatomical mapping systems such as the CARTO 
(Biosense Webster, diamond bar, CA, USA) and Endocardial Solutions 
(St Jude Medical, St Paul, MN, USA) systems have improved our 
understanding of the rhythm circuits and the exact anatomy of the 
suspect atrium. Despite the advent of newer catheter technology (large 
tips, cooled tips, etc.) one big hurdle is the thickness of the atrial wall, 
which may preclude successful ablation despite successful mapping and 
understanding of the rhythm.(13) 
Antitachycardia pacing is an option in some patients. While it does not 
prevent the arrhythmia, it can successfully convert ~50% of arrhythmia 
episodes with decrease in emergency room visits and hospitalizations.(14) 
Currently available options include the Enrhythm pacemaker 
(Medtronic). The additional advantage of these pacemakers is the 
prevention of bradycardia. 
Surgical ablation is a last resort option in some patients. The Fontan 
patient is the one that most needs this option. Dr Mavroudis and 
colleagues from Children’s Memorial Hospital in Chicago have 
demonstrated the benefi ts of converting patients from the older style 
Fontan operation (atrio-pulmonary connection) to the newer style 
extra-cardiac connection, combined with creation of a right atrial Maze, 
and implantation of a pacemaker. However, this approach is not without 
signifi cant morbidity and some mortality.(15) 
ATRIAL FIBRILLATION                                                      
Atrial fi brillation (AF) may be the result of chronic left atrial pressure or 
volume stress as seen in patients with chronic left heart lesions (aortic, 
mitral disease or unrepaired single ventricle, etc.) or the end stage of 
chronic uncontrolled IART. It tends to differ from AF in non-CHD 
patients as seen by large fi brillatory waves in the ECG (Figure 2). Some 
patients may present with an intermediary stage between AFL and AF 
with periods that tend to look more organized than others. Nevertheless, 
 FIGURE 2: Atrial ﬁ brillation in an adult Fontan patient. Note the coarse ﬁ brillatory waves in the V1 rhythm strip.
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from the electrophysiologic point of view, the atriums are in electrical 
chaos and the patient has a high risk of thromboembolic problems. 
Apart from anticoagulation, therapy tends to be limited to two options: 
drugs versus surgical Maze operation. Catheter ablation has not so far 
been described. While pacing has been suggested to prevent AF, this is 
not proven in the CHD patient. 
VENTRICULAR TACHYCARDIA                                         
VT is mainly seen in patients who have had surgical scars in the ventricle 
or those who have had longstanding ventricular hypertrophy or 
dilatation or both. The combination of scar-hypertrophy-dilation seems 
to be the most important. Scar alone may not be as arrhythmogenic as 
seen by the relative paucity of VT in patients who have only had a VSD 
closure. The combination of dilatation-hypertrophy may also be 
arrhythmogenic as seen in patients who have had longstanding aortic 
or pulmonary valve disease. In CCTGA or after atrial repair of TGA, the 
systemic RV is enlarged and hypertrophied and can be a source of VT. 
This is the likely mechanism in unoperated patients with ventricular 
pressure/volume overload as well although, in all these groups, micro-
scarring and fi brosis has been demonstrated.(16) 
The literature on VT in CHD is dominated by TOF patients. This is 
probably because this is a relatively homogenous defect which has been 
repairable since the early days of CHD surgery. These patients often 
have residual pulmonary valve problems such as stenosis or, more 
commonly, signifi cant regurgitation. Of these, the severity and duration of 
regurgitation with consequent RV dilation (demonstrable on X-ray, echo, 
MRI and even the ECG with the QRS duration prolongation) seems to 
be the most important offender. Other lesions such as post-Rastelli-type 
repair of double outlet RV are probably just as likely to get VT. 
VT can degenerate to VF and sudden death as seen by the risk of SD 
in patients with VT or the same substrates that cause VT. 
Management of VT consists acutely of electrical (DC current) cardio-
version or pharmacologic conversion with drugs like i.v. lidocaine, 
procainamide or amiodarone. Chronic management with drugs may be 
possible in the rare patient with monomorphic VT who “tolerates” the VT, 
but usually requires the use of class 3 drugs (sotalol or amiodarone) or 
1C drugs (fl ecainide, propafenone). In developed countries, the 
occurrence of VT is usually taken to indicate a high risk of SD with need 
for ICD placement unless the VT is mappable and ablatable either by 
catheter (a rare occurrence as seen by the paucity of reports in the 
literature) or by surgical means. Antitachycardia overdrive pacing out 
of VT may be possible using ICDs. These options are applicable to the 
patient with monomorphic VT. Polymorphic VT seems to affect patients 
with signifi cant ventricular dysfunction and may be a more important 
precursor to sudden death and should be considered an indication for 
an ICD. 
SUDDEN DEATH                                                               
Oechslin et al. showed that sudden death is one of the most common 
modes of late death in patients with CHD. Indeed, in some conditions, it is 
the commonest mode of death. Apart from the very simple defects (such 
as repaired ASD), there is an incidence of SD in almost every defect.(17) 
Silka et al. reported a population-based study of 25-year follow-up after 
surgery for CHD. The incidence of late SD in CHD patients is ~0.9/1,000 
patient-years. This compares unfavorably to the general risk of 1 per 
25 000 to 100 000 patient-years in persons <20 years. They found that 
4 diagnostic categories accounted for 90% of late sudden deaths: 
tetralogy of Fallot, D-transposition of the great arteries, coarctation of 
the aorta and aortic stenosis. The SD rate for patients with these defects 
was 2.2/1000 patient-years as compared to 0.14/1000 for patients with 
left to right shunt lesions or pulmonary stenosis. Eisenmenger’s 
syndrome is also an important sub-group with risk of SD.(18) 
The cause of SD is thought to be VT/VF in most cases. However, the 
possibility that AFL/AF/IART immediately precedes SD is not yet 
disproven. The advent of implantable defi brillators has changed the 
outlook for patients felt to be at risk of SD. However, ICDs come with 
enough disadvantages to make them impractial for every patient with a 
serious CHD. These disadvantages include the need for surgery (which 
sometimes has to quite creative, as noted in the section on pacing), the 
need for multiple surgeries, inappropriate shocks (which are more 
common in younger patients), and cost. These factors make it important 
to determine who exactly is at risk for SD. 
As far as risk stratifi cation is concerned, the literature on SD is also 
heavily tilted towards TOF. Some of the factors that have been shown 
to infl uence risk of SD are: older age at surgery, wide QRS (>180ms) 
on the ECG, frequent and complex ventricular ectopics, RV dilation, and 
positive electrophysiologic studies.(19) Despite much work, risk 
stratifi cation remains imprecise. Apart from the symptomatic patient 
with syncope, dizziness, and rarely, near-miss SD, who shows some of 
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benefi t from an ICD. A positive EP study with induction of sustained VT 
or VF may help but non-inducibility does not rule out risk of SD.(20-22) 
Risk stratifi cation in the asymptomatic patient is even more diffi cult. The 
role of primary prevention of SD using an ICD remains open to study. 
SD in patients after atrial repair of TGA has been shown to be associated 
with prior episodes of IART and with symptoms of heart failure.(23) This 
reinforces the notion of a detrimental vicious circle with heart failure and 
atrial arrhythmias eventually leading to ventricular failure and SD. However, 
the possibility that IART with acute deterioration of ventricular function 
and development of VF is the cause of SD cannot be disproved. 
Anecdotally, many episodes of SD seem to happen during exercise or 
exertion. Therefore, activity recommendations with restriction from 
strenuous sports or exercise are important in patients thought to be at 
risk for SD. 
CONCLUSIONS                                                                 
Arrhythmias are a big challenge in ACHD patients. The complexity of 
the underlying anatomy, poor response to the usual therapies and 
signifi cant hemodynamic deterioration secondary to arrhythmias, make 
it imperative that clinicians stay pro-active and vigilant in caring for 
these patients. 
Much knowledge has been gained in the past two decades and 
signifi cant advances have been made, including the advent of catheter 
ablation, ICDs, and newer drugs (e.g. amiodarone). Despite this, much 
work remains. There is hope that the trend towards earlier repair of 
CHD, more physiologic repair (e.g. the arterial switch compared to 
the Mustard’s/Senning’s operation) and newer surgical modifi cations 
(e.g. avoiding transannular patching in tetralogy, the extracardiac conduit 
Fontan, etc.) may prevent or, at least, retard the development of 
arrhythmias in the future. Further innovations such as newer drugs and 
improved ablation techniques will also play a role in improving the 
outlook for these patients. Indeed, we must remember that in many 
patients, arrhythmias are the result of success, not failure.
13059 SAHJ journal October.indd   39 11/8/07   9:35:48 AM
